Umbilical cord-derived mesenchymal stem cells for hematopoietic stem cell transplantation
- PMID: 23093863
- PMCID: PMC3471031
- DOI: 10.1155/2012/759503
Umbilical cord-derived mesenchymal stem cells for hematopoietic stem cell transplantation
Abstract
Hematopoietic stem cell transplantation (HSCT) is becoming an effective therapeutic modality for a variety of diseases. Mesenchymal stem cells (MSCs) can be used to enhance hematopoietic engraftment, accelerate lymphocyte recovery, reduce the risk of graft failure, prevent and treat graft-versus-host disease, and repair tissue damage in patients receiving HSCT. Till now, most MSCs for human clinical application have been derived from bone marrow. However, acquiring bone-marrow-derived MSCs involves an invasive procedure. Umbilical cord is rich with MSCs. Compared to bone-marrow-derived MSCs, umbilical cord-derived MSCs (UCMSCs) are easier to obtain without harm to the donor and can proliferate faster. No severe adverse effects were noted in our previous clinical application of UCMSCs in HSCT. Accordingly, application of UCMSCs in humans appears to be feasible and safe. Further studies are warranted.
Similar articles
-
Cotransplantation of umbilical cord-derived mesenchymal stem cells promote hematopoietic engraftment in cord blood transplantation: a pilot study.Transplantation. 2013 Mar 15;95(5):773-7. doi: 10.1097/TP.0b013e31827a93dd. Transplantation. 2013. PMID: 23274973
-
Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.Stem Cell Rev Rep. 2017 Feb;13(1):35-49. doi: 10.1007/s12015-016-9702-4. Stem Cell Rev Rep. 2017. PMID: 27853939 Review.
-
The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.Stem Cell Res Ther. 2019 Jun 21;10(1):182. doi: 10.1186/s13287-019-1287-9. Stem Cell Res Ther. 2019. PMID: 31227011 Free PMC article. Review.
-
The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides.Cell Transplant. 2013;22(4):723-9. doi: 10.3727/096368912X655217. Epub 2012 Oct 12. Cell Transplant. 2013. PMID: 23068433 Review.
-
A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment.Stem Cells Dev. 2011 Mar;20(3):547-57. doi: 10.1089/scd.2010.0260. Epub 2010 Nov 9. Stem Cells Dev. 2011. PMID: 20923277
Cited by
-
Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility.Int J Mol Sci. 2023 Feb 24;24(5):4464. doi: 10.3390/ijms24054464. Int J Mol Sci. 2023. PMID: 36901900 Free PMC article. Review.
-
Human umbilical cord mesenchymal stromal cells suppress MHC class II expression on rat vascular endothelium and prolong survival time of cardiac allograft.Int J Clin Exp Med. 2014 Jul 15;7(7):1760-7. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25126177 Free PMC article.
-
Stem cell therapies in age-related neurodegenerative diseases and stroke.Ageing Res Rev. 2017 Mar;34:39-50. doi: 10.1016/j.arr.2016.11.002. Epub 2016 Nov 19. Ageing Res Rev. 2017. PMID: 27876573 Free PMC article. Review.
-
Mir-218 contributes to the transformation of 5-Aza/GF induced umbilical cord mesenchymal stem cells into hematopoietic cells through the MITF pathway.Mol Biol Rep. 2014 Jul;41(7):4803-16. doi: 10.1007/s11033-014-3351-y. Epub 2014 Apr 3. Mol Biol Rep. 2014. PMID: 24696000
-
Adipose-derived mesenchymal cells for bone regereneration: state of the art.Biomed Res Int. 2013;2013:416391. doi: 10.1155/2013/416391. Epub 2013 Nov 7. Biomed Res Int. 2013. PMID: 24307997 Free PMC article. Review.
References
-
- Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. Journal of Embryology and Experimental Morphology. 1966;16(3):381–390. - PubMed
-
- Su BH, Wu KH, Lin HY, Lin MH, Peng CT, Tsai C. Umbilical cord-derived mesenchymal stem cells for severe bronchpulmonary dysplasia. Pediatrics. 2011;126(125):1127–1133.
-
- Wu KH, Chan CK, Tsai C, et al. Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation. 2011;91(12):1412–1416. - PubMed
-
- Chao YH, Tsai C, Peng CT, et al. Cotransplantation of umbilical cord MSCs to enhance engraftment of hematopoietic stem cells in patients with severe aplastic anemia. Bone Marrow Transplantation. 2011;46(10):1391–1392. - PubMed
-
- Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–317. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical